These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21388807)

  • 1. Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.
    Rueeger H; Rondeau JM; McCarthy C; Möbitz H; Tintelnot-Blomley M; Neumann U; Desrayaud S
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1942-7. PubMed ID: 21388807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
    Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
    J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1017-21. PubMed ID: 18166458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
    Sund C; Belda O; Borkakoti N; Lindberg J; Derbyshire D; Vrang L; Hamelink E; Åhgren C; Woestenenk E; Wikström K; Eneroth A; Lindström E; Kalayanov G
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6721-7. PubMed ID: 23010268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.
    Ng RA; Sun M; Bowers S; Hom RK; Probst GD; John V; Fang LY; Maillard M; Gailunas A; Brogley L; Neitz RJ; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Adler M; Yao N; Zmolek W; Nakamura D; Quinn KP; Sauer JM; Bova MP; Ruslim L; Artis DR; Yednock TA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4674-9. PubMed ID: 23856050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.
    Thompson LA; Shi J; Decicco CP; Tebben AJ; Olson RE; Boy KM; Guernon JM; Good AC; Liauw A; Zheng C; Copeland RA; Combs AP; Trainor GL; Camac DM; Muckelbauer JK; Lentz KA; Grace JE; Burton CR; Toyn JH; Barten DM; Marcinkeviciene J; Meredith JE; Albright CF; Macor JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6909-15. PubMed ID: 21974952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.
    Sealy JM; Truong AP; Tso L; Probst GD; Aquino J; Hom RK; Jagodzinska BM; Dressen D; Wone DW; Brogley L; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Dappen MS; Toth G; Pan H; Ruslim L; Miller J; Bova MP; Sinha S; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6386-91. PubMed ID: 19811916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors.
    Hanessian S; Shao Z; Betschart C; Rondeau JM; Neumann U; Tintelnot-Blomley M
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1924-7. PubMed ID: 20172717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1.
    Marcin LR; Higgins MA; Zusi FC; Zhang Y; Dee MF; Parker MF; Muckelbauer JK; Camac DM; Morin PE; Ramamurthy V; Tebben AJ; Lentz KA; Grace JE; Marcinkeviciene JA; Kopcho LM; Burton CR; Barten DM; Toyn JH; Meredith JE; Albright CF; Bronson JJ; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Jan; 21(1):537-41. PubMed ID: 21078556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies toward improving the brain penetration of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Moore KP; Zhu H; Rajapakse HA; McGaughey GB; Colussi D; Price EA; Sankaranarayanan S; Simon AJ; Pudvah NT; Hochman JH; Allison T; Munshi SK; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5831-5. PubMed ID: 17827011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
    Xu W; Chen G; Zhu W; Zuo Z
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6203-7. PubMed ID: 20850315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
    Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
    Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
    Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
    Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential virtual screening approach to the identification of small organic molecules as potential BACE-1 inhibitors.
    Chiriano G; Sartini A; Mancini F; Andrisano V; Bolognesi ML; Roberti M; Recanatini M; Carloni P; Cavalli A
    Chem Biol Drug Des; 2011 Apr; 77(4):268-71. PubMed ID: 21244641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.